全球流感診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

流感診斷市場預計將從 2025 年的 15.2 億美元成長到 2034 年的 28.7 億美元，2026 年至 2034 年的複合年成長率為 7.31%。

由於人們對感染疾病的認知不斷提高，全球流感診斷市場正在成長。季節性流感爆發以及早期檢測的需求推動了對診斷測試的需求。醫療機構正致力於快速且準確的檢測，以防止感染傳播。新冠肺炎疫情也促進了全球診斷基礎設施的完善。

快速檢測套組和分子診斷技術的進步是推動市場成長要素。醫療保健支出不斷成長以及政府疾病監測措施也促進了市場成長。醫院和診斷檢查室正在擴大檢測能力，意識提升，進一步推動了市場需求。

隨著更精準、更便攜的檢測方案的開發，市場預計未來將持續成長。對研發和公共衛生計畫的投入將創造新的機會。然而，季節性需求波動可能會影響收入穩定性。儘管如此，人們對疾病預防和應對措施日益成長的關注預計將支撐市場的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球流感診斷市場：依產品分類

• 市場分析、洞察與預測
• 檢測套組
• 裝置

第5章：全球流感診斷市場：依檢測方法分類

• 市場分析、洞察與預測
• 常規診斷測試
• 快速流感檢測
• 血清學檢測
• 直接螢光測定
• 病毒培養
• H1N1甲型流感病毒鑑定試劑盒
• 分子診斷測試
• 聚合酵素鏈鎖反應
• 恒溫核酸增幅檢測
• 轉錄媒介增幅的檢測方法
• 基於恒溫環型核酸擴增的檢測方法
• 基於核酸序列的擴增檢測
• 其他等恒溫核酸增幅試驗
• 其他

第6章：全球流感診斷市場：依類型分類

• 市場分析、洞察與預測
• 甲型流感
• 乙型流感
• 丙型流感

第7章 全球流感診斷市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 臨床檢查室
• 研究和學術機構
• 受託研究機構

第8章 全球流感診斷市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • Becton, Dickinson And Company（BD）
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Hologic Inc
  • Siemens Healthineers
  • Quidel Corporation
  • BioMAfA（C）Rieux
  • Meridian Bioscience Inc
  • DiaSorin SpA
  • Sekisui Diagnostics
  • Luminex Corporation
  • Tecan Trading AG
  • Altona Diagnostics GmbH
  • GenMark Diagnostics Inc

The Influenza Diagnostics Market size is expected to reach USD 2.87 Billion in 2034 from USD 1.52 Billion (2025) growing at a CAGR of 7.31% during 2026-2034.

The global influenza diagnostics market has grown due to increased awareness about infectious diseases. Seasonal flu outbreaks and the need for early detection have boosted demand for diagnostic tests. Healthcare providers focus on quick and accurate testing to prevent the spread of infection. The COVID-19 pandemic also strengthened diagnostic infrastructure worldwide.

Key drivers include technological advancements in rapid testing kits and molecular diagnostics. Growing healthcare spending and government initiatives for disease surveillance support market growth. Hospitals and diagnostic laboratories are expanding their testing capabilities. Increasing public awareness about timely diagnosis further drives demand.

In the future, the market is expected to expand with the development of more accurate and portable testing solutions. Investment in research and public health programs will create opportunities. However, seasonal demand fluctuations may affect revenue stability. Despite this, rising focus on disease prevention and preparedness will support long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Test Kits
• Instruments

By Test

• Traditional Diagnostic Test
• Rapid influenza detection tests
• Serological assays
• Direct fluorescent antibodies
• Viral culture
• H1N1 influenza A virus identification kits
• Molecular Diagnostic Tests
• Polymerase Chain Reaction
• Isothermal Nucleic Acid Amplification Tests
• Transcription-Mediated Amplification-Based Assay
• Loop-Mediated Isothermal Amplification-Based Assay
• Nucleic Acid Sequence-Based Amplification Tests
• Other Isothermal Nucleic Acid Amplification Tests
• Others

By Type

• Type A Flu
• Type B Flu
• Type C Flu

By End-Use

• Hospitals
• Clinical Laboratories
• Research and Academic Institutes
• Contract Research Organizations

COMPANIES PROFILED

• Abbott Laboratories, Becton, Dickinson and Company BD, F HoffmannLa Roche Ltd, Thermo Fisher Scientific Inc, Hologic Inc, Siemens Healthineers, Quidel Corporation, bioMrieux, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics, Luminex Corporation, Tecan Trading AG, altona Diagnostics GmbH, GenMark Diagnostics Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INFLUENZA DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN and Units)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 5. GLOBAL INFLUENZA DIAGNOSTICS MARKET: BY TEST 2022-2034 (USD MN and Units)

• 5.1. Market Analysis, Insights and Forecast Test
• 5.2. Traditional Diagnostic Test Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.3. Rapid influenza detection tests Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.4. Serological assays Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.5. Direct fluorescent antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.6. Viral culture Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.7. H1N1 influenza A virus identification kits Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.8. Molecular Diagnostic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.9. Polymerase Chain Reaction Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.10. Isothermal Nucleic Acid Amplification Tests Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.11. Transcription-Mediated Amplification-Based Assay Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.12. Loop-Mediated Isothermal Amplification-Based Assay Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.13. Nucleic Acid Sequence-Based Amplification Tests Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.14. Other Isothermal Nucleic Acid Amplification Tests Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.15. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 6. GLOBAL INFLUENZA DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN and Units)

• 6.1. Market Analysis, Insights and Forecast Type
• 6.2. Type A Flu Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.3. Type B Flu Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.4. Type C Flu Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 7. GLOBAL INFLUENZA DIAGNOSTICS MARKET: BY END-USE 2022-2034 (USD MN and Units)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 7.3. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 7.4. Research and Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 7.5. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 8. GLOBAL INFLUENZA DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN and Units)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 8.2.1 By Product
  • 8.2.2 By Test
  • 8.2.3 By Type
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 8.3.1 By Product
  • 8.3.2 By Test
  • 8.3.3 By Type
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 8.4.1 By Product
  • 8.4.2 By Test
  • 8.4.3 By Type
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 8.5.1 By Product
  • 8.5.2 By Test
  • 8.5.3 By Type
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 8.6.1 By Product
  • 8.6.2 By Test
  • 8.6.3 By Type
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL INFLUENZA DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Abbott Laboratories
  • 10.2.2 Becton, Dickinson And Company (BD)
  • 10.2.3 F. Hoffmann-La Roche Ltd
  • 10.2.4 Thermo Fisher Scientific Inc
  • 10.2.5 Hologic Inc
  • 10.2.6 Siemens Healthineers
  • 10.2.7 Quidel Corporation
  • 10.2.8 BioMAfA(C)Rieux
  • 10.2.9 Meridian Bioscience Inc
  • 10.2.10 DiaSorin SpA
  • 10.2.11 Sekisui Diagnostics
  • 10.2.12 Luminex Corporation
  • 10.2.13 Tecan Trading AG
  • 10.2.14 Altona Diagnostics GmbH
  • 10.2.15 GenMark Diagnostics Inc